Correction to: Cost‑Effectiveness of Empirical Bismuth‑Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication
- PMID: 34014441
- DOI: 10.1007/s10620-021-07061-8
Correction to: Cost‑Effectiveness of Empirical Bismuth‑Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication
Erratum for
-
Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.Dig Dis Sci. 2022 Apr;67(4):1222-1230. doi: 10.1007/s10620-021-06938-y. Epub 2021 Mar 23. Dig Dis Sci. 2022. PMID: 33755825
Publication types
LinkOut - more resources
Full Text Sources